Professor Sir Rory Collins
Colleges
Websites
-
UK Biobank
Principal Investigator and Chief Execuitve
-
British Heart Foundation
Professor of Medicine and Epidemiology
-
Tokai University
Adjunctive Professor
-
China Oxford Centre for International Health Research
Honorary Director
-
Beijing Union Medical College and Chinese Academy of Medical Sciences
Honorary Professor
Rory Collins
FRS, FMedSci
Head of Oxford Population Health and BHF Professor of Medicine and Epidemiology
Rory Collins studied Medicine at St Thomas’s Hospital Medical School, London University (1974-1980), and Statistics at George Washington University (1976-7) and at the University of Oxford (1982-3).
In 1985 he became co-director, with Professor Sir Richard Peto, of the University of Oxford's Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU). In 1996, he was appointed Professor of Medicine and Epidemiology at Oxford, supported by the British Heart Foundation.
He became Principal Investigator and Chief Executive of the UK Biobank prospective study of 500,000 people in September 2005. From July 2013, he became the Head of Oxford Population Health at Oxford University.
His work has been in the establishment of large-scale epidemiological studies of the causes, prevention and treatment of heart attacks, other vascular disease, and cancer. He was knighted in 2011 for his services to science.
Key publications
-
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
Journal article
Baigent C. et al, (2005), Lancet, 366, 1267 - 1278
-
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
Journal article
Antithrombotic Trialists' Collaboration None., (2002), BMJ, 324, 71 - 86
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.
Journal article
Heart Protection Study Collaborative Group None., (2002), Lancet, 360, 7 - 22
Recent publications
-
One-size-fits-all versus risk-category-based screening interval strategies for cardiovascular disease prevention in Chinese adults: a prospective cohort study
Journal article
Sun Z. et al, (2024), The Lancet Regional Health - Western Pacific, 49
-
Causal relevance of different blood pressure traits on risk of cardiovascular diseases: GWAS and Mendelian randomisation in 100,000 Chinese adults
Journal article
CHEN Z. et al, (2024), Nature Communications
-
A deep catalogue of protein-coding variation in 983,578 individuals.
Journal article
Sun KY. et al, (2024), Nature, 631, 583 - 592
-
Methods applied to neonatal dried blood spot samples for secondary research purposes: a scoping review.
Journal article
Canning J. et al, (2024), Crit Rev Clin Lab Sci, 1 - 24
-
Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis.
Journal article
Cholesterol Treatment Trialists’ (CTT) Collaboration. Electronic address: ctt@ndph.ox.ac.uk None. and Cholesterol Treatment Trialists’ (CTT) Collaboration None., (2024), Lancet Diabetes Endocrinol, 12, 306 - 319